Role of Sympathetic Nervous System in the Metabolic Syndrome and Sleep Apnea

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This article will review the role of the sympathetic nervous system in the pathogenesis of metabolic syndrome and sleep apnea and the pathophysiological link between these two clinical conditions. Several indices of adrenergic tone have all shown an increase in the different conditions clustering in the metabolic syndrome. The adrenergic overdrive appears to be potentiated in the metabolic syndrome and contributes at the cardiovascular, structural, and functional alterations typical of this condition. Several mechanisms, supporting the hyperadrenergic state in metabolic syndrome, are also present in another pathophysiological condition, such as obstructive sleep apnea, which contributes to determining the increased cardiovascular risk of these patients. The data reviewed herein support the relevance of the sympathetic nervous system in the pathogenesis of the metabolic syndrome and sleep apnea and highlight the importance of the sympathomodulation as a specific aim of therapeutic intervention to reduce the cardiovascular risk and the morbidity of these pathophysiological conditions.

Original languageEnglish
Title of host publicationModulation of Sleep by Obesity, Diabetes, Age, and Diet
PublisherElsevier Inc.
Pages165-175
Number of pages11
ISBN (Print)9780124202405, 9780124201682
DOIs
Publication statusPublished - Sep 15 2014

Fingerprint

Sympathetic Nervous System
Sleep Apnea Syndromes
Adrenergic Agents
Obstructive Sleep Apnea
Cluster Analysis
Morbidity
Therapeutics

Keywords

  • Adrenergic modulation
  • Cardiovascular risk
  • Metabolic syndrome
  • Reflex mechanisms
  • Sleep apnea
  • Sympathetic nervous system

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Role of Sympathetic Nervous System in the Metabolic Syndrome and Sleep Apnea. / Seravalle, Gino; Grassi, Guido.

Modulation of Sleep by Obesity, Diabetes, Age, and Diet. Elsevier Inc., 2014. p. 165-175.

Research output: Chapter in Book/Report/Conference proceedingChapter

Seravalle, Gino ; Grassi, Guido. / Role of Sympathetic Nervous System in the Metabolic Syndrome and Sleep Apnea. Modulation of Sleep by Obesity, Diabetes, Age, and Diet. Elsevier Inc., 2014. pp. 165-175
@inbook{973e303fa5da45319f31acfc26af6a49,
title = "Role of Sympathetic Nervous System in the Metabolic Syndrome and Sleep Apnea",
abstract = "This article will review the role of the sympathetic nervous system in the pathogenesis of metabolic syndrome and sleep apnea and the pathophysiological link between these two clinical conditions. Several indices of adrenergic tone have all shown an increase in the different conditions clustering in the metabolic syndrome. The adrenergic overdrive appears to be potentiated in the metabolic syndrome and contributes at the cardiovascular, structural, and functional alterations typical of this condition. Several mechanisms, supporting the hyperadrenergic state in metabolic syndrome, are also present in another pathophysiological condition, such as obstructive sleep apnea, which contributes to determining the increased cardiovascular risk of these patients. The data reviewed herein support the relevance of the sympathetic nervous system in the pathogenesis of the metabolic syndrome and sleep apnea and highlight the importance of the sympathomodulation as a specific aim of therapeutic intervention to reduce the cardiovascular risk and the morbidity of these pathophysiological conditions.",
keywords = "Adrenergic modulation, Cardiovascular risk, Metabolic syndrome, Reflex mechanisms, Sleep apnea, Sympathetic nervous system",
author = "Gino Seravalle and Guido Grassi",
year = "2014",
month = "9",
day = "15",
doi = "10.1016/B978-0-12-420168-2.00018-1",
language = "English",
isbn = "9780124202405",
pages = "165--175",
booktitle = "Modulation of Sleep by Obesity, Diabetes, Age, and Diet",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Role of Sympathetic Nervous System in the Metabolic Syndrome and Sleep Apnea

AU - Seravalle, Gino

AU - Grassi, Guido

PY - 2014/9/15

Y1 - 2014/9/15

N2 - This article will review the role of the sympathetic nervous system in the pathogenesis of metabolic syndrome and sleep apnea and the pathophysiological link between these two clinical conditions. Several indices of adrenergic tone have all shown an increase in the different conditions clustering in the metabolic syndrome. The adrenergic overdrive appears to be potentiated in the metabolic syndrome and contributes at the cardiovascular, structural, and functional alterations typical of this condition. Several mechanisms, supporting the hyperadrenergic state in metabolic syndrome, are also present in another pathophysiological condition, such as obstructive sleep apnea, which contributes to determining the increased cardiovascular risk of these patients. The data reviewed herein support the relevance of the sympathetic nervous system in the pathogenesis of the metabolic syndrome and sleep apnea and highlight the importance of the sympathomodulation as a specific aim of therapeutic intervention to reduce the cardiovascular risk and the morbidity of these pathophysiological conditions.

AB - This article will review the role of the sympathetic nervous system in the pathogenesis of metabolic syndrome and sleep apnea and the pathophysiological link between these two clinical conditions. Several indices of adrenergic tone have all shown an increase in the different conditions clustering in the metabolic syndrome. The adrenergic overdrive appears to be potentiated in the metabolic syndrome and contributes at the cardiovascular, structural, and functional alterations typical of this condition. Several mechanisms, supporting the hyperadrenergic state in metabolic syndrome, are also present in another pathophysiological condition, such as obstructive sleep apnea, which contributes to determining the increased cardiovascular risk of these patients. The data reviewed herein support the relevance of the sympathetic nervous system in the pathogenesis of the metabolic syndrome and sleep apnea and highlight the importance of the sympathomodulation as a specific aim of therapeutic intervention to reduce the cardiovascular risk and the morbidity of these pathophysiological conditions.

KW - Adrenergic modulation

KW - Cardiovascular risk

KW - Metabolic syndrome

KW - Reflex mechanisms

KW - Sleep apnea

KW - Sympathetic nervous system

UR - http://www.scopus.com/inward/record.url?scp=84945986958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945986958&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-420168-2.00018-1

DO - 10.1016/B978-0-12-420168-2.00018-1

M3 - Chapter

AN - SCOPUS:84945986958

SN - 9780124202405

SN - 9780124201682

SP - 165

EP - 175

BT - Modulation of Sleep by Obesity, Diabetes, Age, and Diet

PB - Elsevier Inc.

ER -